Pancreatic Cancer Drug Shows Promise in Lung Cancer Trial
A groundbreaking drug for pancreatic cancer is now showing promise against the most common form of lung cancer. In a small trial, the drug shrank tumors in 31 to 37 percent of patients, depending on the dose. The next step is a larger trial.
NBC News Health
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from NBC News Health.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
NBC News Health (www.today.com), a Tier C publisher, filed this report on . CurrentWire published this page 27 minutes later, on .
Signal breakdown
CurrentWire ranked this story 60.2 of 100 in the snapshot this page was rendered from.
- Freshness
- 33.7 of 35
- Source authority
- 9 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 10 of 10
- Velocity
- 0 of 5
Strongest signal: story prominence, 10 of 10. How each signal is calculated.
Filed under Health · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: Cancer Drug Shows Promise (none), Lung Cancer Trial (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.